Hepatocellular carcinoma: molecular mechanisms and targeted therapies
A Alqahtani, Z Khan, A Alloghbi, T S. Said Ahmed… - Medicina, 2019 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the most common and lethal malignant tumors
worldwide. HCC is a complex process that is associated with several etiological factors …
worldwide. HCC is a complex process that is associated with several etiological factors …
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
G Khemlina, S Ikeda, R Kurzrock - Molecular cancer, 2017 - Springer
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is a leading
cause of cancer-related death worldwide. It is highly refractory to most systemic therapies …
cause of cancer-related death worldwide. It is highly refractory to most systemic therapies …
Comprehensive characterization of molecular differences in cancer between male and female patients
An individual's sex has been long recognized as a key factor affecting cancer incidence,
prognosis, and treatment responses. However, the molecular basis for sex disparities in …
prognosis, and treatment responses. However, the molecular basis for sex disparities in …
Landscape of phosphatidylinositol-3-kinase pathway alterations across 19 784 diverse solid tumors
SZ Millis, S Ikeda, S Reddy, Z Gatalica… - JAMA oncology, 2016 - jamanetwork.com
Importance Molecular aberrations in the phosphatidylinositol-3-kinase (PI3K) pathway drive
tumorigenesis. Frequently co-occurring alterations in hormone receptors and/or human …
tumorigenesis. Frequently co-occurring alterations in hormone receptors and/or human …
The crucial role of multiomic approach in cancer research and clinically relevant outcomes
M Lu, X Zhan - EPMA Journal, 2018 - Springer
Cancer with heavily economic and social burden is the hot point in the field of medical
research. Some remarkable achievements have been made; however, the exact …
research. Some remarkable achievements have been made; however, the exact …
[HTML][HTML] Genetic alterations in hepatocellular carcinoma: An update
ZS Niu, XJ Niu, WH Wang - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths
worldwide. Although recent advances in therapeutic approaches for treating HCC have …
worldwide. Although recent advances in therapeutic approaches for treating HCC have …
Molecular pathogenesis of nonalcoholic steatohepatitis‐(NASH‐) related hepatocellular carcinoma
The proportion of obese or diabetic population has been anticipated to increase in the
upcoming decades, which rises the prevalence of nonalcoholic fatty liver disease (NAFLD) …
upcoming decades, which rises the prevalence of nonalcoholic fatty liver disease (NAFLD) …
Hepatocellular carcinoma in non-alcoholic fatty liver disease: from epidemiology to diagnostic approach
Simple Summary Non-alcoholic fatty liver disease (NAFLD) is expected to become the
leading cause of hepatocellular carcinoma (HCC) in the near future. In this article, we review …
leading cause of hepatocellular carcinoma (HCC) in the near future. In this article, we review …
[HTML][HTML] Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma
S Talamantes, M Lisjak, EH Gilglioni… - JHEP Reports, 2023 - Elsevier
Obesity-related complications such as non-alcoholic fatty liver disease (NAFLD) and type 2
diabetes (T2D) are well-established risk factors for the development of hepatocellular …
diabetes (T2D) are well-established risk factors for the development of hepatocellular …
TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication
Objective We investigated the mutational landscape of mammalian target of rapamycin
(mTOR) signalling cascade in hepatocellular carcinomas (HCCs) with chronic HBV …
(mTOR) signalling cascade in hepatocellular carcinomas (HCCs) with chronic HBV …